$2.77
10.80% today
Nasdaq, Apr 02, 10:00 pm CET
ISIN
US05479K1060
Symbol
ELUT
Sector
Industry

Aziyo Biologics Inc - Ordinary Shares - Class A Stock price

$2.77
-0.37 11.78% 1M
-1.04 27.30% 6M
-0.97 25.94% YTD
-0.31 10.06% 1Y
-3.53 56.03% 3Y
-14.23 83.71% 5Y
-14.23 83.71% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
+0.27 10.80%
ISIN
US05479K1060
Symbol
ELUT
Sector
Industry

Key metrics

Market capitalization $102.16m
Enterprise Value $123.55m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 5.07
P/S ratio (TTM) P/S ratio 4.19
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth -31.04%
Revenue (TTM) Revenue $24.38m
EBIT (operating result TTM) EBIT $-24.28m
Free Cash Flow (TTM) Free Cash Flow $-23.31m
Cash position $13.24m
EPS (TTM) EPS $-2.48
P/E forward negative
P/S forward 3.07
EV/Sales forward 3.71
Short interest 0.17%
Show more

Is Aziyo Biologics Inc - Ordinary Shares - Class A a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Aziyo Biologics Inc - Ordinary Shares - Class A Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a Aziyo Biologics Inc - Ordinary Shares - Class A forecast:

2x Buy
100%

Analyst Opinions

2 Analysts have issued a Aziyo Biologics Inc - Ordinary Shares - Class A forecast:

Buy
100%

Financial data from Aziyo Biologics Inc - Ordinary Shares - Class A

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
24 24
31% 31%
100%
- Direct Costs 14 14
41% 41%
56%
11 11
13% 13%
44%
- Selling and Administrative Expenses 28 28
11% 11%
114%
- Research and Development Expense 3.79 3.79
23% 23%
16%
-21 -21
18% 18%
-85%
- Depreciation and Amortization 3.45 3.45
7% 7%
14%
EBIT (Operating Income) EBIT -24 -24
14% 14%
-100%
Net Profit -54 -54
24% 24%
-222%

In millions USD.

Don't miss a Thing! We will send you all news about Aziyo Biologics Inc - Ordinary Shares - Class A directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Aziyo Biologics Inc - Ordinary Shares - Class A Stock News

Neutral
GlobeNewsWire
about 2 hours ago
Introduction of EluPro at Heart Rhythm 2025 in San Diego, April 25-27, 2025 SILVER SPRING, Md., April 02, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, is proud to announce the debut of its EluPro™ Antibiotic-Eluting BioEnvelope designed for cardiac implantable electronic devices (CIEDs) and neurostimulators at the...
Neutral
GlobeNewsWire
6 days ago
Seventh GPO Agreement Signed Since EluPro's Launch SILVER SPRING, Md., March 27, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced that it has entered into an agreement with Advantus Health Partners (“Advantus”), to provide access of Elutia's EluPro™ Antibiotic Eluting BioEnvelope to Advantus' core group purc...
Neutral
GlobeNewsWire
8 days ago
— Rigorous testing demonstrates robust antimicrobial performance against bacterial strains relevant to cardiac implanted electronic device (CIED) infections — SILVER SPRING, Md., March 25, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today announced the publication of new preclinical data in the current issue ...
More Aziyo Biologics Inc - Ordinary Shares - Class A News

Company Profile

Aziyo Biologics, Inc. operates as a biotechnology company which focuses on regenerative medicine in areas such as cardiology, orthopedics and other medical specialties. It offers cardiac device envelope, vascular surgery, cardiothoracic repair, orthopedics and spine, sports medicine, dermal, and wound care. The company was founded on August 6, 2015 and is headquartered in Silver Spring, MD.

Head office United States
CEO Charles Mills
Employees 51
Founded 2015
Website www.elutia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today